Literature DB >> 18209987

[Expanding the liver donor pool through extended-criteria donation].

J Pratschke1, J Mittler, P Neuhaus.   

Abstract

Due to the great shortage of donor organs in liver transplantation, the utilization of liver allografts from extended-criteria donors is gaining importance. An accepted precise definition of extended-criteria donors remains elusive. The most frequent criteria include high donor age, graft steatosis, and prolonged ICU stay. The influence of using extended-criteria donors on post-transplant outcome has yet to be defined. Its possibly higher rates of graft dysfunction and impaired graft and recipient survival are countered by a proven reduction in waiting-list mortality. Moreover, recipient factors of particular risk such as high MELD (model for endstage liver disease) score and underlying hepatitis C infection have to be defined and taken into consideration.

Entities:  

Mesh:

Year:  2008        PMID: 18209987     DOI: 10.1007/s00104-007-1458-6

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  23 in total

1.  Marginal donors in liver transplantation: the role of donor age.

Authors:  L De Carlis; G Colella; C V Sansalone; P Aseni; G F Rondinara; A O Slim; F Di Benedetto; A Giacomoni; R Fesce; D Forti
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

2.  Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient?

Authors:  Daniel G Maluf; Erick B Edwards; H Myron Kauffman
Journal:  Transplantation       Date:  2006-12-27       Impact factor: 4.939

Review 3.  Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation.

Authors:  S M Strasberg; T K Howard; E P Molmenti; M Hertl
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

4.  A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.

Authors:  R M Ghobrial; R Steadman; J Gornbein; C Lassman; C D Holt; P Chen; D G Farmer; H Yersiz; N Danino; E Collisson; A Baquarizo; S S Han; S Saab; L I Goldstein; J A Donovan; K Esrason; R W Busuttil
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

5.  Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia.

Authors:  E Totsuka; F Dodson; A Urakami; N Moras; T Ishii; M C Lee; J Gutierrez; M Gerardo; E Molmenti; J J Fung
Journal:  Liver Transpl Surg       Date:  1999-09

6.  Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.

Authors:  Gerd R Silberhumer; Herwig Pokorny; Hubert Hetz; Harald Herkner; Susanne Rasoul-Rockenschaub; Thomas Soliman; Thomas Wekerle; Gabriela A Berlakovich; Rudolf Steininger; Ferdinand Muehlbacher
Journal:  Transplantation       Date:  2007-03-15       Impact factor: 4.939

7.  Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers.

Authors:  N R Barshes; I B Horwitz; L Franzini; J M Vierling; J A Goss
Journal:  Am J Transplant       Date:  2007-03-12       Impact factor: 8.086

8.  Analysis of donor criteria for the prediction of outcome in clinical liver transplantation.

Authors:  L Makowka; R D Gordon; S Todo; N Ohkohchi; J W Marsh; A G Tzakis; H Yokoi; J Ligush; C O Esquivel; M Satake
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

9.  Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation.

Authors:  Kenneth D Chavin; Ryan N Fiorini; Stephen Shafizadeh; Gang Cheng; Chidan Wan; Zachary Evans; David Rodwell; Carmen Polito; Julia K Haines; G Mark Baillie; Michael G Schmidt
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

10.  Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.

Authors:  Sammy Saab; Albert J Chang; Scott Comulada; Sunil K Geevarghese; R Dean M Anselmo; Francisco Durazo; Steven Han; Douglas G Farmer; Hasan Yersiz; Leonard I Goldstein; R Mark Ghobrial; Ronald W Busuttil
Journal:  Liver Transpl       Date:  2003-10       Impact factor: 5.799

View more
  2 in total

1.  Influence of autologous blood transfusion in liver transplantation in patients with hepatitis B on the function and hemorheology of red blood cells.

Authors:  Xiangfu Liu; Ruifang Fan; Ying Lu; Lihua Kuang; Qing Yuan; Yuchan Chen; Zhesheng Lin; Dongjun Lin
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

2.  [Extended donor criteria defined by the German Medical Association : study on their usefulness as prognostic model for early outcome after liver transplantation].

Authors:  H Schrem; B Reichert; N Frühauf; M Kleine; L Zachau; T Becker; F Lehner; H Bektas; J Klempnauer
Journal:  Chirurg       Date:  2012-11       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.